Aug 2026· International Conference on Multimedia Analysis and Pattern Recognition· pp. 448-453· 0 citations· 19 references
Abstract
Alzheimer’s disease (AD) is a progressive neurode-generative disorder for which early and accurate diagnosis is critical for clinical management. Effective diagnosis depends on both disease staging and continuous cognitive monitoring through the Mini-Mental State Examination (MMSE), yet most existing deep learning-based methods predict these two targets with separate models, and the few joint multi-task approaches struggle to balance classification and regression during training. To overcome these limitations, we propose CFML, a multitask architecture that integrates 3D MRI and demographic metadata through cross-modal fusion and attention-based feature gating, producing task-tailored representations for joint AD stage classification and MMSE regression. Within CFML, we introduce the T-Hybrid Loss, a dual-branch adaptive task-weighting strategy that fuses loss-aware and gradient-aware signals through a dispersion-driven coefficient, simultaneously correcting cross-task scale mismatch and gradient dominance. Comprehensive evaluations on ADNI-1, ADNI-2, and AIBL show that CFML achieves 97.32% accuracy with 1.43 (RMSE) MMSE on ADNI-1 and 97.35% accuracy with 1.45 (RMSE) MMSE in the combined three-class AD/CN/MCI setting, outperforming recent single-task and multi-task baselines.
The proposed GBP-SCMF provides an effective and interpretable multimodal strategy for computer-aided AD diagnosis and integrates three complementary mechanisms: generative brain-prior enhancement to inject disease-related pathological knowledge into imaging representations, self-regulated multimodal alignment to reduce...
Yi-bo Huang, Xiao-Long Guo, Zhiyi Li et al.· Journal of imaging informati...· 0 citations
A multimodal deep learning classification framework integrating structural magnetic resonance imaging (sMRI) and clinical features and an adaptive gated fusion module that dynamically integrates concatenated global multimodal features with cross-modal interaction features is proposed.
Xiao-Li Yang, Chen-Chen Wang, Xiao Li et al.· Biomedical engineering and p...· 0 citations
Alzheimer’s disease (AD) is the leading cause of dementia and a major cause of death worldwide, making early detection a critical clinical priority. Because pathological changes may begin 15–20 years before symptom onset, artificial intelligence (AI) has emerged as a promising tool for identifying and characterizing AD...
José Menezes, M. I. Barbosa, P. M. Rodrigues· Italian National Conference...· 0 citations
Early and accurate classification of Alzheimer's disease (AD) stages from magnetic resonance imaging (MRI) remains a critical challenge in clinical neuroimaging, particularly for distinguishing early-stage cognitive decline from normal aging. Existing deep learning approaches applied to publicly available augmented MRI...
NeuroFusion achieves state-of-the-art brain age prediction on the OpenBHB benchmark and maintains strong performance with only 5 labelled examples, demonstrating clinically relevant generalizatio in few-shot adaptation to unseen sites.
Molla Md Rony, Rahman Md Takibur, Md. Emran Hossain Dipu et al.· International Journal of Adv...· 0 citations
A key aspect of diagnosing Alzheimer’s disease (AD) is identifying mild cognitive impairment (MCI), a sensitive transitional stage between normal cognition (NC) and AD. We divided AD disease progression into three stages: NC, MCI, and AD according to severity. We used CoopLearning to integrate multi-view medical da...
Yan-Hong Luo, Nan Dai, Yu Qiao et al.· Frontiers in Aging Neuroscie...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.